Acute adrenal infection by HSV-1: role of apoptosis in viral replication

被引:16
|
作者
Aita, K
Irie, H
Koyama, AH
Fukuda, A
Yoshida, T
Shiga, J
机构
[1] Teikyo Univ, Sch Med, Dept Pathol, Itabashi Ku, Tokyo 1738605, Japan
[2] Univ Tokushima, Sch Med, Dept Virol, Tokushima 770, Japan
[3] Chugai Pharmaceut Co Ltd, Chuo Res Labs, Tokyo, Japan
关键词
D O I
10.1007/s007050170048
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Replication of herpes simplex virus type 1 (HSV-1) in the adrenal gland of mice was observed 12 h after intravenous inoculation, peaked at 48 h (7 x 10(7) PFU/tissue), and was maintained until death. Virus spread to the bilateral intermediolateral column of the thoracic spinal cord. Infected cells appeared in the fascicular zone of the adrenal cortex 12 h after infection, and cell death was evident in lesions found in the adrenal cortex. Lesions involved the medulla 48 h after inoculation. In cortical lesions, cell nuclei were fragmented or shrunken with little damage to the cytoplasm. DNA fragmentation appeared 12h after inoculation and increased mainly in cortical lesions, which were characterized by apoptosis induced by HSV-1 infection. In the adrenal medulla, cells were fused and formed multinucleated giant cells but rarely displayed cell death. Macrophages, which serve as a frontal barrier to viral infection in the adrenal gland, especially the cortex, were fewer in number than those found in the liver or spleen. It is likely that HSV-1 easily infects the adrenal gland, resulting in suppression of local immunity, and that adrenal cell apoptosis serves as a primitive type of immunity to limit viral replication.
引用
收藏
页码:2009 / 2020
页数:12
相关论文
共 50 条
  • [41] Human lactoferrin but not lysozyme neutralizes HSV-1 and inhibits HSV-1 replication and cell-to-cell spread
    Valimaa, Hannamari
    Tenovuo, Jorma
    Waris, Matti
    Hukkanen, Veijo
    VIROLOGY JOURNAL, 2009, 6
  • [42] The HSV-1 encoded CCCTC-binding factor, CTRL2, impacts the nature of viral chromatin during HSV-1 lytic infection
    Singh, Pankaj
    Zhu, Liqian
    Shipley, Mason A.
    Ye, Ziyun A.
    Neumann, Donna M.
    PLOS PATHOGENS, 2024, 20 (10)
  • [43] Assessing the role of perforin in controlling acute cutaneous HSV-1 infections
    Rajasagi, Naveen K.
    Jennings, Stephen R.
    JOURNAL OF NEUROVIROLOGY, 2006, 12 : 68 - 69
  • [44] Inhibition of HSV-1 replication by a gene editing strategy
    Bellizzi, Anna
    Wollebo, Hassen S.
    Caocci, Maurizio
    De Chiara, Giovanna
    Palamara, Anna T.
    Gordon, Jennifer
    Khalili, Kamel
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2018, 13 : S5 - S5
  • [45] Deciphering AAV replication strategy in the presence of HSV-1
    Nicolas, A.
    Alazard-Dany, N.
    Biollay, C.
    Arata, L.
    Jolinon, N.
    Kuhn, L.
    Ferro, M.
    Weller, S. K.
    Epstein, A. L.
    Greco, A.
    Salvetti, A.
    HUMAN GENE THERAPY, 2010, 21 (10) : 1397 - 1397
  • [46] Inhibition of HSV-1 replication by a gene editing strategy
    Bellizzi, Anna
    Roehm, Pamela C.
    Shekarabi, Masoud
    Wollebo, Hassen S.
    Ibba, Gabriele
    White, Martyn K.
    He, Lifan
    Salkind, Julian
    Khalili, Kamel
    JOURNAL OF NEUROVIROLOGY, 2016, 22 : S7 - S8
  • [47] microRNA role in HSV-1 latency
    Gueudin, M.
    VIROLOGIE, 2008, 12 (05) : 388 - 389
  • [48] Development of replication - Conditional HSV-1 as glioma therapy
    Brown, S. M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 : 6 - 7
  • [49] Inhibition of HSV-1 Replication by Gene Editing Strategy
    Pamela C. Roehm
    Masoud Shekarabi
    Hassen S. Wollebo
    Anna Bellizzi
    Lifan He
    Julian Salkind
    Kamel Khalili
    Scientific Reports, 6
  • [50] Inhibition of HSV-1 Replication by Gene Editing Strategy
    Roehm, Pamela C.
    Shekarabi, Masoud
    Wollebo, Hassen S.
    Bellizzi, Anna
    He, Lifan
    Salkind, Julian
    Khalili, Kamel
    SCIENTIFIC REPORTS, 2016, 6